Panbela Therapeutics, Inc.
PBLADelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted in 2026; its insiders filed their last Form 4 on Nov 19, 2024; no institution reported holding it in 13F filings for Q4 2025; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Panbela Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Panbela Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Soon-Shiong Patrick | 10% Owner | – | Nov 19, 2024 | 0 |
| Nant Capital, LLC | 10% Owner | – | Nov 19, 2024 | 0 |
| Horvath Susan | V.P. of Finance & CFO | 17,880 | Oct 3, 2024 | 0 |
| Simpson Jennifer K. | President and CEO | 7,868 | Oct 3, 2024 | 0 |
| Goldman Sachs & Co. LLC | 10% Owner | 397,954Indirect | Nov 13, 2023 | 0 |
| Goldman Sachs Group Inc | 10% Owner | 397,954Indirect | Nov 13, 2023 | 0 |
| Jacob Jeffrey E. | Director | 0Indirect | Sep 14, 2023 | 0 |
| Mathiesen Jeffrey S | Director | – | Mar 29, 2023 | 0 |
| Fratamico Arthur | Director | – | Mar 29, 2023 | 0 |
| Schemel Donald Robert | Director, 10% Owner | 482,654Indirect | Mar 29, 2023 | 0 |
| Cullen Michael T. | Director, 10% Owner | 369,576Indirect | Mar 29, 2023 | 0 |
| Donovan Daniel | Director | – | Mar 29, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 (view filing)6:40 PM ET | Nov 15 | 4 days | Soon-Shiong Patrick and 1 other10% Owner | PPurchase | +24.7M | – | – | – | DerivativePrice outlier |
| Nov 13, 2023 (view filing)7:29 PM ET | Nov 8 | 5 days | Goldman Sachs & Co. LLC and 1 other10% Owner | SSale | −72.9K | $0.71 | −$51.7K | −15.5%398.0K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Simpson Jennifer K.President and CEO | PPurchase | +4.44K | – | – | +129.8%7.87K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Simpson Jennifer K.President and CEO | PPurchase | +8.89K | $0.00 | $0 | –8.89K after | Derivative |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Horvath SusanV.P. of Finance & CFO | PPurchase | +4.44K | – | – | +33.1%17.9K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Horvath SusanV.P. of Finance & CFO | PPurchase | +8.89K | $0.00 | $0 | –8.89K after | Derivative |
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Cullen Michael T.Director, 10% Owner | PPurchase | +165.0K | – | – | +80.7%369.6K after | |
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Cullen Michael T.Director, 10% Owner | PPurchase | +247.0K | $0.00 | $0 | –247.0K after | Derivative |
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Schemel Donald RobertDirector, 10% Owner | PPurchase | +200.0K | – | – | +70.8%482.7K after | |
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Schemel Donald RobertDirector, 10% Owner | PPurchase | +300.0K | $0.00 | $0 | –300.0K after | Derivative |
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Jacob Jeffrey E.Director | PPurchase | +33.0K | – | – | +12.6%294.9K after | |
| Oct 6, 2022 (view filing) | Oct 4 | 2 days | Jacob Jeffrey E.Director | PPurchase | +49.5K | $0.00 | $0 | –49.5K after | Derivative |